Molecular mechanisms of inherited insulin resistance

QJM: An International Journal of Medicine

Volumn 90, Issue 9, 1997, Pages 557-562

  Baynes, K C R ^a   Whitehead, J ^a   Krook, A ^b   O'Rahilly, S ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

GENETIC DISORDER; INSULIN RESISTANCE; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

EID: 0030967460     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.9.557     Document Type: Review

References (49)

1. White MF, Kahn CR. The insulin signaling system. J Biol Chem 1994; 269(1):1-4.
2. Moller DE, O'Rahilly S. Syndromes of severe insulin resistance: Clinical and pathophysiological features. In: Moller DE, ed. Insulin resistance. Chichester UK, Wiley, 1993:49-81.
3. Krook A, O'Rahilly S. Mutant insulin receptors in syndromes of insulin resistance. Bailliere's Clin Endocrinol Metab 1996; 10(1):97-122.
4. Accili D, Cama A, Barbeti F, et al. Insulin resistance due to mutations of the insulin receptor gene - an overview. J Endocrinol Invest 1992; 15(11):857-64.
5. Moller DE, Cohen O, Yamaguchi Y, et al. Prevalence of mutations of the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 1994; 43:247-55.
6. Sun XJ, Rothenberg P, Kahn CR, et al. Structure of the insulin receptor IRS-1 defines a unique signal transduction protein. Nature 1991; 352:73-7.
7. Almind K, Bjorbaek C, Vestergaard H, et al. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin dependent diabetes mellitus. Lancet 1993; 342:828-32.
8. Almind K, Inoue G, Pedersen O, et al. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signalling. J Clin Invest 1996; 97(11):2569-75.
9. Tamemoto H, Kadowaki T, Tobe K, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994; 372:182-6.
10. Araki E, Lipes MA, Patti ME, et al. Alternative pathway of insulin sigalling in mice with targeted disruption of the IRS-1 gene. Nature 1994; 372:186-90.
11. Whitehead J, Humphries P, Krook A, et al. A naturally occurring mutation in IRS-1 responsible for severe insulin resistance in a human patient? Exp Clin Endocrinol Diabetes 1996; 104(Suppl. 2):64-5.
12. Shepherd P, Nave B, O'Rahilly S. The role of phosphoinositide 3-kinase in insulin signalling. J Mol Endocrinol 1996; 17(3):175-84.
13. Inukai K, Anai M, van Breda E, et al. A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK is generated by alternative splicing of the p85α gene. J Biol Chem 1996; 271:5317-20.
14. Hansen T, Andersen CB, Echwald SM, et al. Identification of a amino acid polymorphism in the p85α regulatory subunit of phosphatidylinositol 3-kinase. Diabetes 1997; 46:494-501.
15. Reynet C, Kahn CR. Rad - A member of the Ras family overexpressed in muscle of type-II diabetic humans. Science 1993; 262:1441-4.
16. Orho M, Carlsson M, Kanninen T, et al. Polymorphism at the rad gene is not associated with NIDDM in Finns. Diabetes 1996; 45:429-33.
17. Doria A, Caldwell JS, JI L, et al. Trinucleotide repeats at the rad locus. Diabetes 1995; 44(2):243-7.
18. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity linked resistance. Science 1993; 259(5091):87-91.
19. Ohno Y, Aoki N, Nishimura A. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-α in insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 77:1072-7.
20. Feinstein R, Kanety H, Papa MZ, et al. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993; 268: 26055-8.
21. Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science 1996; 271:665-8.
22. Stephens JM, Pekala PH. Transcriptional repression of the Glut4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-α. J Biol Chem 1991; 266:21839-45.
23. Garvey WT, Maianu L, Hancock JA, et al. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 1992; 41:465-75.
24. Hotamisligil GS, Budavari A, Murray D, et al. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J Clin Invest 1994; 94:1543-9.
25. Ofei F, Hurel S, Newkirk J, et al. Effects of an engineered human anti TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996; 45:881-5.
26. Sbraccia P, Goodman PA, Maddux BA, et al. Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM. Diabetes 1991; 40:295-9.
27. Maddux BA, Sbraccia P, Reaven GM, et al. Inhibitors of insulin receptor tyrosine kinase in fibroblasts from diverse patients with impaired insulin action: Evidence for a novel mechanism of postreceptor insulin resistance. J Clin Endocrin Metab 1993; 77(1):73-9.
28. Maddux BA, Sbraccia P, Kumakura S, et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 1995; 373:448-51.
29. Uriarte M, Stalmans W, Hickman S, et al. Regulation of purified hepatic PC-1 (phosphodiesterase-1/nucleotide pyrophosphatase) by threonine auto(de)phosphorylation and by binding of acidic fibroblast growth factor. Biochem J 1995; 306:271-7.
30. Oda Y, Kuo M, Huang SS, et al. The plasma cell membrane glycoprotein, PC-1, is a threonine-specific protein kinase stimulated by acidic fibroblast growth factor. J Biol Chem 1991; 266:16791-5.
31. Stefan C, Wera S, Stalmans W, et al. The inhibition of the insulin receptor by the membrane protein PC-1 is not specific and results from the hydrolysis of ATP. Diabetes 1996; 45:980-3.
32. Frittitta L, Youngren J, Vigneri R, et al. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia 1996; 39:1190-5.
33. Bruning JC, Winnay J, Bonner-Weir S, et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 1997; 88: 561-72.
34. Hanis C, Boerwinkle E, Chakraborty R, et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome-2. Nature Genetics 1996; 13: 161-6.
35. Hurel S, Rochford JJ, Borthwick AC, et al. Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem J 1996; 320:871-7.
36. Taylor SI, Moller DE. Mutations of the insulin receptor gene. In: Moller DE, ed. Insulin resistance. Chichester UK, Wiley, 1993: 83-113.
37. Imai Y, Fusco A, Suzuki Y, et al. Variant sequences of insulin receptor substrate-1 in patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994; 79:1655-8.
38. Choi WH, O'Rahilly S, Buse JB, et al. Molecular scanning of the insulin responsive glucose transporter (GLUT-4) gene in patients with non-insulin dependent diabetes mellitus. Diabetes 1991; 40:1712-18.
39. Buse JB, Yasuda K, Lay TP, et al. Human GLUT4/muscle-fat glucose-transporter gene: characterisation and genetic variation. Diabetes 1992; 41:1436-45.
40. Bjorbaek C, Echwald SM, Hubricht P, et al. Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT 4 genes in NIDDM. Diabetes 1994; 43:976-83.
41. Hamman RF. Genetic and environmental determinants of non-insulin dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 1992; 8:287-338.
42. Chen YH, Hansen L, Chen MX, et al. Sequence of the human glycogen-associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM. Diabetes 1994; 43:1234-41.
43. Hansen L, Hansen T, Vestergaard H, et al. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase 1 is associated with insulin resistance and hypersecretion of insulin. Hum Mol Genet 1995; 4:1313-20.
44. Vestergaard H, Bjorbaek C, Andersen PH, et al. Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 1991; 40:1740-5.
45. Vidal-Puig A, Printz RL, Stratton IM, et al. Analysis of the hexokinase II gene in subjects with insulin resistance and NIDDM and detection of a Gln1 42 His substitution. Diabetes 1995; 44:340-6.
46. Echwald SM, Bjorbaek C, Hansen T, et al. Identification of four amino acid substitutions in hexokinase II and studies of relationship to NIDDM, glucose effectiveness and insulin sensitivity. Diabetes 1995; 44: 347-53.
47. Bjorbaek C, Vik TA, Echwald SM, et al. Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients. Diabetes 1995; 44: 90-7.
48. Prochazka M, Lillioja S, Tait JF, et al. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 1993; 42:514-19.
49. Humphreys P, McCarthy M, Tuomilehto J, et al. Chromosome 4q locus associated with insulin resistance in Pima Indians. Diabetes 1994; 43:800-4.